Back to PCRX
BlackRock, Inc. PCRX Position History
Pacira BioSciences, Inc. • Healthcare
Quarters held
61
Latest value
$4.8M
Q3 2026
Peak value
$121.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $3M |
| Q4 2025 | $4K |
| Q4 2025 | $6K |
| Q4 2025 | $4.7M |
| Q4 2025 | $6.7M |
| Q4 2025 | $121.2M |
| Q4 2025 | $38.5M |
| Q4 2025 | $203K |
| Q4 2025 | $519K |
| Q4 2025 | $231K |
| Q4 2025 | $3.4M |
| Q4 2025 | $3K |
| Q4 2025 | $212K |
| Q4 2025 | $8K |
| Q4 2025 | $4.3M |
| Q1 2026 | $2.7M |
| Q1 2026 | $4K |
| Q1 2026 | $6K |
| Q1 2026 | $3.8M |
| Q1 2026 | $5.4M |
| Q1 2026 | $99.9M |
| Q1 2026 | $32.6M |
| Q1 2026 | $177K |
| Q1 2026 | $395K |
| Q1 2026 | $177K |
| Q1 2026 | $3.2M |
| Q1 2026 | $3K |
| Q1 2026 | $185K |
| Q1 2026 | $7K |
| Q1 2026 | $3.6M |
| Q2 2026 | $3.6M |
| Q2 2026 | $4K |
| Q2 2026 | $6K |
| Q2 2026 | $3.9M |
| Q2 2026 | $6.8M |
| Q2 2026 | $111M |
| Q2 2026 | $35.9M |
| Q2 2026 | $216K |
| Q2 2026 | $444K |
| Q2 2026 | $199K |
| Q2 2026 | $3.6M |
| Q2 2026 | $132K |
| Q2 2026 | $3K |
| Q2 2026 | $208K |
| Q2 2026 | $4.1M |
| Q2 2026 | $1K |
| Q3 2026 | $4.1M |
| Q3 2026 | $4K |
| Q3 2026 | $6K |
| Q3 2026 | $3.8M |
| Q3 2026 | $7.4M |
| Q3 2026 | $111M |
| Q3 2026 | $37.6M |
| Q3 2026 | $26K |
| Q3 2026 | $72K |
| Q3 2026 | $490K |
| Q3 2026 | $557K |
| Q3 2026 | $3.6M |
| Q3 2026 | $3K |
| Q3 2026 | $205K |
| Q3 2026 | $4.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.8M | 193.3K | — | — |
| Q3 2026 | $205K | 8.2K | — | — |
| Q3 2026 | $3K | 114 | — | — |
| Q3 2026 | $3.6M | 144.6K | — | — |
| Q3 2026 | $557K | 22.2K | — | — |
| Q3 2026 | $490K | 19.6K | — | — |
| Q3 2026 | $72K | 2.9K | — | — |
| Q3 2026 | $26K | 1.1K | — | — |
| Q3 2026 | $37.6M | 1.50M | — | — |
| Q3 2026 | $111M | 4.43M | — | — |
| Q3 2026 | $7.4M | 295.2K | — | — |
| Q3 2026 | $3.8M | 151.4K | — | — |
| Q3 2026 | $6K | 250 | — | — |
| Q3 2026 | $4K | 172 | — | — |
| Q3 2026 | $4.1M | 165.1K | — | — |
| Q2 2026 | $1K | 41 | — | — |
| Q2 2026 | $4.1M | 160.8K | — | — |
| Q2 2026 | $208K | 8.2K | — | — |
| Q2 2026 | $3K | 114 | — | — |
| Q2 2026 | $132K | 5.2K | — | — |
| Q2 2026 | $3.6M | 142.3K | — | — |
| Q2 2026 | $199K | 7.8K | — | — |
| Q2 2026 | $444K | 17.5K | — | — |
| Q2 2026 | $216K | 8.5K | — | — |
| Q2 2026 | $35.9M | 1.42M | — | — |
| Q2 2026 | $111M | 4.38M | — | — |
| Q2 2026 | $6.8M | 267.4K | — | — |
| Q2 2026 | $3.9M | 151.8K | — | — |
| Q2 2026 | $6K | 250 | — | — |
| Q2 2026 | $4K | 172 | — | — |
| Q2 2026 | $3.6M | 143.7K | — | — |
| Q1 2026 | $3.6M | 158.9K | — | — |
| Q1 2026 | $7K | 324 | — | — |
| Q1 2026 | $185K | 8.2K | — | — |
| Q1 2026 | $3K | 114 | — | — |
| Q1 2026 | $3.2M | 142.1K | — | — |
| Q1 2026 | $177K | 7.8K | — | — |
| Q1 2026 | $395K | 17.5K | — | — |
| Q1 2026 | $177K | 7.8K | — | — |
| Q1 2026 | $32.6M | 1.44M | — | — |
| Q1 2026 | $99.9M | 4.42M | — | — |
| Q1 2026 | $5.4M | 240.8K | — | — |
| Q1 2026 | $3.8M | 167.4K | — | — |
| Q1 2026 | $6K | 250 | — | — |
| Q1 2026 | $4K | 172 | — | — |
| Q1 2026 | $2.7M | 118.9K | — | — |
| Q4 2025 | $4.3M | 166.1K | — | — |
| Q4 2025 | $8K | 324 | — | — |
| Q4 2025 | $212K | 8.2K | — | — |
| Q4 2025 | $3K | 114 | — | — |
| Q4 2025 | $3.4M | 130.7K | — | — |
| Q4 2025 | $231K | 8.9K | — | — |
| Q4 2025 | $519K | 20.0K | — | — |
| Q4 2025 | $203K | 7.8K | — | — |
| Q4 2025 | $38.5M | 1.49M | — | — |
| Q4 2025 | $121.2M | 4.68M | — | — |
| Q4 2025 | $6.7M | 257.5K | — | — |
| Q4 2025 | $4.7M | 180.8K | — | — |
| Q4 2025 | $6K | 250 | — | — |
| Q4 2025 | $4K | 172 | — | — |
| Q4 2025 | $3M | 114.1K | — | — |
Other funds holding PCRX
$152.3M
$114.6M